Figure 3.

Patients with or without genetic changes between diagnosis and relapse. (A) One hundred thirteen patients in our study were divided into those who relapsed after allo-SCT and those who did not. Patients were further classified according to those where changes to the profile of genetic aberrations, either in karyotype or in genetic mutations between diagnosis and relapse. n, number of patients. (B) Graph showing 13 patients who had changes (gains and losses) of the number of genetic mutations between diagnosis and relapse.